Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 5 May 2026 - Mint
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 5 May 2026Mint
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 17 March 2026 - Mint
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 17 March 2026Mint
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy and sell today - 10 March 2026 - Mint
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy and sell today - 10 March 2026Mint
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy and sell today - 10 March 2026
Shares to buy or sell: Chandan Taparia has recommended two stocks to buy today, 10 March 2026, and one stock to sell. Taparia recommends buying Torrent Pharmaceuticals and MCX shares today, while selling Maruti Suzuki stock futures.
Laurus Labs shares are up 100% in the last 12 months and Motilal Oswal sees further upside
Motilal Oswal expects Laurus Labs to end financial year 2026 with a Profit After Tax (PAT) of ₹850 crore and reach ₹1,150 crore by financial year 2028, implying a Compounded Annual Growth Rate (CAGR) of 16% by this period.
Stocks to buy or sell: Chandan Taparia of Motilal Oswal recommends three shares to buy and sell today - 20 February 2026
Shares to buy or sell: Chandan Taparia has recommended two stocks to buy today, 20 February 2026 - Oil and Natural Gas Corporation (ONGC) and RBL Bank shares - and has suggested selling Info Edge (India) stock futures.
Stocks to buy or sell: Chandan Taparia of Motilal Oswal recommends three shares to buy and sell today - 20 February 2026 - Mint
Stocks to buy or sell: Chandan Taparia of Motilal Oswal recommends three shares to buy and sell today - 20 February 2026Mint
Buy Niva Bupa Health Insurance; target of Rs 100: Motilal Oswal
Motilal Oswal recommended is bullish on Niva Bupa Health Insurance recommended buy rating on the stock with a target price of Rs 100 in its research report dated Jun 19, 2026.
Neutral Torrent Pharma; target of Rs 4300: Motilal Oswal
Motilal Oswal recommended Neutral rating on Torrent Pharma with a target price of Rs 4300 in its research report dated February 14, 2026.
Neutral Lupin; target of Rs 2360: Motilal Oswal
Motilal Oswal recommended Neutral rating on Lupin with a target price of Rs 2360 in its research report dated February 14, 2026.
Neutral Eris Lifesciences; target of Rs 1520: Motilal Oswal
Motilal Oswal recommended Neutral rating on Eris Lifesciences with a target price of Rs 1520 in its research report dated February 14, 2026.
Neutral ALKEM Laboratories; target of Rs 5525: Motilal Oswal
Motilal Oswal recommended Neutral rating on ALKEM Laboratories with a target price of Rs 5525 in its research report dated February 14, 2026.